| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/24/2011 | WO2010080769A4 Chemotherapeutic methods and compositions |
| 02/24/2011 | WO2010040508A8 Bispecific anti-vegf/anti-ang-2 antibodies |
| 02/24/2011 | WO2009099641A3 Stabilized protein compositions |
| 02/24/2011 | US20110047631 Heat shock protein deficiencies as model systems for brain pathology and cancer |
| 02/24/2011 | US20110047103 Anti-angiogenesis therapy for the treatment of previously treated breast cancer |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046073 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
| 02/24/2011 | US20110045605 Characterization of Granulocytic Ehrlichia and Methods of Use |
| 02/24/2011 | US20110045060 Kit for detecting cancer cells metastasizing into sentinel lymph node |
| 02/24/2011 | US20110045059 Vaccine against varicella zoster virus |
| 02/24/2011 | US20110045057 Virosomes Comprising Hemagglutinin Derived from an Influenza Virus Produced in a Cell Line, Compositions, Methods of Manufacturing, Use Thereof |
| 02/24/2011 | US20110045049 Immunomodulating compositions and methods of use |
| 02/24/2011 | US20110045046 Glycopeptides and methods of making and using them |
| 02/24/2011 | US20110045027 Adjuvant |
| 02/24/2011 | US20110045026 Production of fungal extracellular immune stimulating compounds |
| 02/24/2011 | US20110045025 Pharmaceutical Compositions Containing Clostridium Difficile Toxoids A and B |
| 02/24/2011 | US20110045024 Rna virus vaccines and methods |
| 02/24/2011 | US20110045023 Recombinant RSV Virus Expression Systems And Vaccines |
| 02/24/2011 | US20110045022 Vaccines including antigen from four strains of influenza virus |
| 02/24/2011 | US20110045021 Sugar immunogens |
| 02/24/2011 | US20110045020 Nucleic acid comprising chimeric gene derived from hepatitis c virus |
| 02/24/2011 | US20110045019 Porcine torque teno virus vaccines and diagnosis |
| 02/24/2011 | US20110045018 Astrovirus species |
| 02/24/2011 | US20110045017 Hiv vaccine for mucosal delivery |
| 02/24/2011 | US20110045016 Utilization of recombinant influenza viruses and modified vaccinia ankara virus (mva) with genes that encode for the toxoplasma gondii sag1 and sag2 surface proteins, as vaccines against toxoplasmosis |
| 02/24/2011 | US20110045015 Conjugated beta-1,3-linked glucans |
| 02/24/2011 | US20110045013 CAT Allergen Conjugates and Uses Thereof |
| 02/24/2011 | US20110045012 Anti-atheroma vaccine |
| 02/24/2011 | US20110045011 TRUNCATED RECOMBINANT MAJOR OUTER MEMBRANE PROTEIN ANTIGEN (R56) OF ORIENTIA TSUTSUGAMUSHI STRAINS KARP, KATO and GILLIAM AND ITS USE IN ANTIBODY BASED DETECTION ASSAYS AND VACCINES |
| 02/24/2011 | US20110045010 Anti-lps factor from parietaria judaica and methods of use thereof |
| 02/24/2011 | US20110045009 Cell Permeable Peptide |
| 02/24/2011 | US20110045008 Therapeutic agents for inducing platelet fragmentation and treating thromboembolic disorders |
| 02/24/2011 | US20110045007 Fusion or linked proteins with extended half life |
| 02/24/2011 | US20110045006 LUCA2 and Antibodies That Bind Thereto |
| 02/24/2011 | US20110045005 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 02/24/2011 | US20110045004 Method for in-vitro detecting pathogenic t helper cells and pharmaceutical compositions for treating autoimmune diseases |
| 02/24/2011 | US20110045003 Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders |
| 02/24/2011 | US20110045002 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 02/24/2011 | US20110045001 Transfection results of non-viral gene delivery systems by influencing of the innate immune system |
| 02/24/2011 | US20110045000 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/24/2011 | US20110044999 Il-32 modulators |
| 02/24/2011 | US20110044998 Stabilized Angiopoietin-2 Antibodies And Uses Thereof |
| 02/24/2011 | US20110044997 Methods |
| 02/24/2011 | US20110044996 Neutralizing antibodies |
| 02/24/2011 | US20110044995 Anti-hiv monoclonal antibody |
| 02/24/2011 | US20110044994 Human immunodeficiency virus (hiv)-neutralizing antibodies |
| 02/24/2011 | US20110044993 Method for the prevention and treatment of cancer by inhibition of gpvi |
| 02/24/2011 | US20110044992 Method of delivering an anti-cancer agent to a cell |
| 02/24/2011 | US20110044991 Methods and compositions for treating lymphoma and myeloma |
| 02/24/2011 | US20110044990 Antibody design using anti-lipid antibody crystal structures |
| 02/24/2011 | US20110044989 Zona Pellucida Binding Peptides, Expression Vectors, Compositions, and Methods for Species Specific Immunocontraception of Animals |
| 02/24/2011 | US20110044988 Methods of treatment using anti-mif antibodies |
| 02/24/2011 | US20110044987 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 02/24/2011 | US20110044986 Anti-amyloid antibodies and uses thereof |
| 02/24/2011 | US20110044985 Antibodies directed against amyloid-beta peptide and methods using same |
| 02/24/2011 | US20110044984 Monoclonal Antibody Capable of Binding to Anexelekto, and Use Thereof |
| 02/24/2011 | US20110044983 Complement inhibitors as therapeutic agents for treatment of cancer |
| 02/24/2011 | US20110044982 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| 02/24/2011 | US20110044981 Methods and compositions for treatment of pulmonary fibrotic disorders |
| 02/24/2011 | US20110044980 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 02/24/2011 | US20110044979 Domain antibody construct |
| 02/24/2011 | US20110044978 Method for treating bone fracture |
| 02/24/2011 | US20110044977 Subcutaneous anti-HER2 antibody formulations and uses thereof |
| 02/24/2011 | US20110044976 Humanized antibodies |
| 02/24/2011 | US20110044975 Treatment of prion protein related diseases |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044973 Treatment of cystic disease with lysophosphatidic acid antagonists |
| 02/24/2011 | US20110044945 Agents for the treatment of multiple sclerosis and methods of using same |
| 02/24/2011 | US20110044942 Methods of treatment for solid tumors |
| 02/24/2011 | US20110044941 Immunotherapy for reversing immune suppression |
| 02/24/2011 | US20110044940 Thiazole Carboxamide Derivatives and Their Use to Treat Cancer |
| 02/24/2011 | US20110044938 Tetrahydrobenzothiophene derivatives |
| 02/24/2011 | US20110044937 Staged immune-response modulation in oncolytic therapy |
| 02/24/2011 | US20110044912 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 02/24/2011 | US20110044906 Methods for the Treatment, the Prognostic Assessment and the Staging of Non-Small Cell Lung Cancer |
| 02/24/2011 | US20110044903 Methods for producing microbubbles |
| 02/24/2011 | US20110044902 Modulation of the Immune Response |
| 02/24/2011 | US20110044896 Tumor-targeting monoclonal antibodies to FZD10 and uses thereof |
| 02/24/2011 | US20110044895 Methods and compositions for reducing stemness in oncogenesis |
| 02/24/2011 | US20110044894 Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof |
| 02/24/2011 | US20110044893 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 02/24/2011 | US20110042260 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 02/24/2011 | DE112008003232T5 Antigen-Bindungskonstrukte Antigen-binding constructs |
| 02/24/2011 | DE10251709C5 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3 |
| 02/24/2011 | CA2772240A1 Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agents |
| 02/24/2011 | CA2771778A1 Methods and compositions for treatment of pulmonary fibrotic disorders |
| 02/24/2011 | CA2771744A1 Antibodies against the ectodomain of erbb3 and uses thereof |
| 02/24/2011 | CA2771630A1 Therapeutic methods and compositions |
| 02/24/2011 | CA2771540A1 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 02/24/2011 | CA2771436A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| 02/24/2011 | CA2771429A1 Use of mimotopes of alpha-synuclein epitopes for treating lewy body diseases |
| 02/24/2011 | CA2771277A1 Cloning and expression of arnox protein transmembrane 9 superfamily (tm9sf), methods and utility |
| 02/24/2011 | CA2771086A1 Anti-angiogenesis therapy for the treatment of previously treated breast cancer |
| 02/24/2011 | CA2769415A1 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes |
| 02/24/2011 | CA2769409A1 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes |
| 02/24/2011 | CA2769407A1 Mimotopes of hiv and uses thereof |
| 02/23/2011 | EP2287617A2 Method for diagnosing neuro-degenerative disease |
| 02/23/2011 | EP2287337A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 02/23/2011 | EP2287316A1 Antigenic polypeptides |
| 02/23/2011 | EP2287315A1 Streptococcus pyogenes antigens |